| P2093 | author name string | N Köhler | |
| | C Laske | |
| | E Stransky | |
| | E Richartz-Salzburger | |
| P2860 | cites work | Telomere shortening in T cells correlates with Alzheimer's disease status | Q51951567 |
| | Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome | Q52168611 |
| | Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients | Q53190577 |
| | Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease | Q53237145 |
| | Senile dementia, Alzheimer type: a distinct entity in the immunosenescence? | Q68084574 |
| | Leukocyte function and life span in a murine model of premature immunosenescence | Q77436690 |
| | Diminished production of proinflammatory cytokines in patients with Alzheimer's disease | Q81334137 |
| | [Current immune therapy for Alzheimer's disease] | Q81429299 |
| | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
| | Inflammation and Alzheimer's disease | Q28138617 |
| | Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse | Q29619237 |
| | Reduced levels of amyloid beta-peptide antibody in Alzheimer disease | Q34090874 |
| | Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease | Q34309544 |
| | Inflammation, autotoxicity and Alzheimer disease | Q34469472 |
| | Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease | Q34960461 |
| | Microglia as neuroprotective, immunocompetent cells of the CNS. | Q34963638 |
| | Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease | Q35047977 |
| | Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down's syndrome (accelerated aging). | Q35163207 |
| | Antibody-mediated immunotherapy for Alzheimer's disease | Q36894612 |
| | Inflammaging as a prodrome to Alzheimer's disease | Q37041389 |
| | Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease | Q37118356 |
| | Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? | Q37294059 |
| | Inflammatory markers and the risk of Alzheimer disease: the Framingham Study | Q40208679 |
| | The immunopathology of Alzheimer's disease and some related disorders | Q40807293 |
| | Neuroautoimmunity: pathogenic implications for Alzheimer's disease | Q41315524 |
| | Replicative Senescence in the Immune System: Impact of the Hayflick Limit on T-Cell Function in the Elderly | Q41739819 |
| | Telomere Dysfunction of Lymphocytes in Patients With Alzheimer Disease | Q44591292 |
| | Bringing basic and clinical research together to an integrated understanding of psychiatric disorders | Q48373073 |
| | Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease | Q48373983 |
| | Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients | Q48813586 |
| P433 | issue | 7 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 837-843 | |
| P577 | publication date | 2010-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Der Nervenarzt | Q15446312 |
| P1476 | title | Premature immunosenescence: a pathogenetic factor in Alzheimer's disease? | |
| P478 | volume | 81 | |